Inactive Instrument

News ContraVir Pharmaceuticals Inc Nasdaq

Equities

US21234W1036

Summary

Unlock all the news: Be the first to know and act before the market!

Hepion Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	22/05	CI
Sector Update: Health Care Stocks Increase Late Afternoon	23/04	MT
Sector Update: Health Care	23/04	MT
Top Midday Decliners	22/04	MT
Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b 'ASCEND-NASH' Trial	22/04	AQ
North American Morning Briefing: Stock Futures Rise, Busy Week of Earnings Ahead	22/04	DJ
Hepion Pharmaceuticals Starts Wind-Down Activities in Phase 2b ASCEND-NASH Trial	20/04	MT
Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b ‘ASCEND-NASH’ Trial	20/04	AQ
Hepion Pharmaceuticals, Inc. Initiates Wind-Down Activities in Phase 2b ?ASCEND-NASH? Trial	20/04	CI
Hepion Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	17/04	CI
Hepion Pharmaceuticals Strengthens Board of Directors with Appointment of Michael Purcell	06/03	AQ
Hepion Pharmaceuticals, Inc. Appoints Michael Purcell to Its Board of Directors	06/03	CI
Hepion Pharmaceuticals, Inc. Announces Board Changes	21/02	CI
Hepion Pharmaceuticals Announces Exercise of Warrants for Approximately $2.0 Million Aggregate Gross Proceeds	16/02	AQ
Hepion Pharmaceuticals, Inc. Announces Resignation of Anand Reddi from the Board of Directors	08/02	CI
Hepion Pharmaceuticals to Present at NASH-TAG 2024	04/01	AQ
North American Morning Briefing : Futures Pause -2-	08/12	DJ
Hepion Pharmaceuticals Announces Restructuring Plan to Enhance Shareholder Value	07/12	CI
Hepion Pharmaceuticals Approves Restructuring Plan to Preserve Capital, Launches Strategic Review Process	07/12	MT
Hepion Pharmaceuticals Announces Restructuring Plan to Enhance Shareholder Value and Management Changes	07/12	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News ContraVir Pharmaceuticals Inc Nasdaq

Equities

US21234W1036

Summary

Filters